Company

WELT Corp.

WELT develops digital therapeutics and biomarker technology for healthcare.

About

Founded in 2016 in Seoul, WELT develops digital therapeutics and digital biomarker technology for healthcare services. It spun off from Samsung Electronics and is led by CEO Sung-ji Kang. In June 2024, it raised KRW 14 billion in Series C funding led by Envisioning Partners, with Korea Development Bank, Shinhan Venture Investment, IMM Investment, and Handok participating. The company planned to support device research, product approvals, and global expansion.

5Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in